Banka Bioloo
BANKA NSE
Banka Bioloo
ConstructionNSE: BANKA Civil Construction
Key Fundamentals
MicrocapCivil ConstructionConstructionMarket Cap
₹85.30 Cr
Volatility
Moderate
P/E Ratio
263.81
EBITDA
₹6.50 Cr
Return on Equity
0.92%
Debt to Equity
1.03
Book Value
₹36.19
52W High
₹97.88
52W Low
₹41
Tapetide Score
Data-driven rating, 0–100. How it works →
Key Insights
Weaknesses
4- Company has low interest coverage ratio.
- Company has a low return on equity of -7.78% over last 3 years.
- Company has high debtors of 186 days.
- Promoter holding has decreased over last 3 years: -3.10%
Growth Rate
Revenue Growth
7.16% lower than
3Y
Net Income Growth
-104% lower than
3Y
Cash Flow Change
20.69% higher than
3Y
ROE
-103% lower than
3Y
ROCE
-149% lower than
3Y
EBITDA Margin (Avg.)
-338% lower than
3Y
Quarterly Results
| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 8.28 | 11.45 | 13.96 | 16.31 | 12.89 | 12.41 | 14.04 | 14.84 | 11.14 | 13.01 | 15.26 | 17.67 | 10.55 |
| Expenses | 9.79 | 9.16 | 12.18 | 15.28 | 11.15 | 16.89 | 14.01 | 15.01 | 10.8 | 13.02 | 13.79 | 14.31 | 8.74 |
| Operating Profit | -1.51 | 2.29 | 1.78 | 1.03 | 1.74 | -4.48 | 0.03 | -0.17 | 0.34 | -0.01 | 1.47 | 3.36 | 1.81 |
| OPM % | -18.24% | 20% | 12.75% | 6.32% | 13.5% | -36.1% | 0.21% | -1.15% | 3.05% | -0.08% | 9.63% | 19.02% | 17.16% |
| Other Income | 0.18 | 0.1 | 0.11 | 0.12 | 0.12 | -0.23 | 0.12 | 0.03 | 1.06 | 0.07 | 0.07 | -0.16 | 0.11 |
| Interest | 0.51 | 0.68 | 0.65 | 0.63 | 0.87 | 0.85 | 1.01 | 1.03 | 0.89 | 0.93 | 0.91 | 0.93 | 1.16 |
| Depreciation | 0.46 | 0.55 | 0.57 | 0.61 | 0.62 | 0.62 | 0.63 | 0.66 | 0.64 | 0.7 | 0.77 | 0.69 | 0.85 |
| PBT | -2.3 | 1.16 | 0.67 | -0.09 | 0.37 | -6.18 | -1.49 | -1.83 | -0.13 | -1.57 | -0.14 | 1.58 | -0.09 |
| Tax % | 1.3% | -5.17% | -2.99% | 166.67% | 21.62% | -0.81% | -2.01% | -12.02% | -100% | -30.57% | -14.29% | -1.9% | -55.56% |
| Net Profit | -2.33 | 1.22 | 0.69 | -0.25 | 0.29 | -6.13 | -1.46 | -1.61 | 0.01 | -1.08 | -0.13 | 1.6 | -0.04 |
| EPS in Rs | -2.15 | 1.12 | 0.65 | -0.22 | 0.27 | -5.65 | -1.35 | -1.49 | 0.01 | -0.99 | -0.14 | 1.45 | -0.01 |
Profit & Loss
| Particulars | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|
| Sales | 47.86 | 30.46 | 38.75 | 42.35 | 50 | 54.18 | 57.09 | 56.49 |
| Expenses | 39.17 | 27.01 | 33.19 | 36.16 | 46.2 | 57.03 | 51.82 | 49.86 |
| Operating Profit | 8.69 | 3.45 | 5.56 | 6.19 | 3.8 | -2.85 | 5.27 | 6.63 |
| OPM % | 18.16% | 11.33% | 14.35% | 14.62% | 7.6% | -5.26% | 9.23% | 11.74% |
| Other Income | 0.45 | 0.58 | 0.48 | 0.71 | 0.49 | 0.05 | 1.02 | 0.09 |
| Interest | 0.83 | 1.56 | 1.79 | 1.79 | 2.66 | 3.79 | 3.75 | 3.93 |
| Depreciation | 0.47 | 0.6 | 0.94 | 1.48 | 2.19 | 2.53 | 2.8 | 3.01 |
| PBT | 7.84 | 1.87 | 3.31 | 3.63 | -0.56 | -9.12 | -0.26 | -0.22 |
| Tax % | 20.66% | -17.65% | 6.04% | 30.03% | 19.64% | -2.41% | -253.85% | — |
| Net Profit | 6.23 | 2.2 | 3.11 | 2.54 | -0.67 | -8.91 | 0.39 | 0.35 |
| EPS in Rs | 6.05 | 2.14 | 2.87 | 2.34 | -0.6 | -8.2 | 0.32 | 0.31 |
| Div. Payout % | 6.6% | 0% | 0% | 0% | 0% | 0% | 0% | — |
Balance Sheet
| Particulars | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Equity Capital | 4.11 | 10.28 | 10.85 | 10.85 | 10.85 | 10.87 | 10.92 |
| Reserves | 23.92 | 19.75 | 26.66 | 29.25 | 28.87 | 20.64 | 28.63 |
| Borrowings | 11.44 | 11.69 | 18.5 | 16.71 | 25.91 | 34.73 | 40.8 |
| Other Liabilities | 7.3 | 4.64 | 8.04 | 8.39 | 11.8 | 15.92 | 20.37 |
| Total Liabilities | 46.77 | 46.36 | 64.05 | 65.2 | 77.43 | 82.16 | 101 |
| Fixed Assets | 4.02 | 5.09 | 6.77 | 10.68 | 15.39 | 15.86 | 27.71 |
| CWIP | 0 | 0 | 2.42 | 3.43 | 6.51 | 7.64 | 0.48 |
| Investments | 0 | 0.02 | 0.05 | 0.06 | 0.02 | 0.04 | 0.07 |
| Other Assets | 42.75 | 41.25 | 54.81 | 51.03 | 55.51 | 58.62 | 72.46 |
| Total Assets | 46.77 | 46.36 | 64.05 | 65.2 | 77.43 | 82.16 | 101 |
Cash Flow
| Particulars | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Operating | -5.56 | 5.86 | -0.44 | 7.35 | 2.76 | 0.87 | 1.05 |
| Investing | -5.06 | -4.7 | -6.68 | -7.46 | -11.81 | -6.02 | -2.16 |
| Financing | 7.15 | -3.69 | 0.95 | -3.33 | 6.78 | 5.08 | 11.07 |
| Net Cash Flow | -3.47 | -2.52 | -6.16 | -3.44 | -2.28 | -0.07 | 9.97 |
| Free Cash Flow | -6.97 | 5.35 | -3.59 | 0.94 | -7.21 | -3.57 | -4.94 |
| CFO/OP | -80 | 135 | 4 | 132 | 93 | -59 | 3 |
Ratios
| Particulars | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Debtor Days | 114 | 140 | 192 | 198 | 168 | 187 | 186 |
| Inventory Days | — | — | 456 | 575 | 186 | — | — |
| Days Payable | — | — | 199 | 208 | 88.38 | — | — |
| Cash Conversion Cycle | 114 | 140 | 449 | 565 | 265 | 187 | 186 |
| Working Capital Days | 149 | 244 | 246 | 177 | 155 | 72.15 | 88.17 |
| ROCE % | — | 8.45% | 10.44% | 9.61% | 3.43% | -7.61% | 5.06% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Banka Bioloo insights
55 extracted metrics + investor summaries across FY12–FY26.
Documents
1
Price movement
8 April 2026 - Investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written … 8 April 2026 - Investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written …
2
Updates on Open Offer
27 Feb - SAT interim order maintains status quo on open offer; next hearing March 25, 2026. 27 Feb - SAT interim order maintains status quo on open offer; next hearing March 25, 2026.
3
Announcement under Regulation 30 (LODR)-Newspaper Publication
12 Feb - Submission of copy of newspaper publication(s) regarding unaudited financial results for the quarter and nine months ended December 31, 2025. 12 Feb - Submission of copy of newspaper publication(s) regarding unaudited financial results for the quarter and nine months ended December 31, 2025.
4
Board Meeting Outcome for Unaudited Standalone & Consolidated Financial Results For The Quarter And Nine Months Ended December 31, 2025
11 Feb - Q3/9M Dec 31,2025: 9M consolidated loss Rs8,444.15 lakh; loan defaults Rs19,458.43 lakh; NCD default Rs432.71 lakh 11 Feb - Q3/9M Dec 31,2025: 9M consolidated loss Rs8,444.15 lakh; loan defaults Rs19,458.43 lakh; NCD default Rs432.71 lakh
Frequently Asked Questions about Banka Bioloo
What does Banka Bioloo Ltd do?
Incorporated in 2012, Banka Bioloo Ltd does manufacturing, supply, installation and O&M
of Bio toilets and Controlled discharge toilet system[1]
Where is Banka Bioloo Ltd (BANKA) listed?
Banka Bioloo Ltd trades as BANKA on the NSE.
Which sector does Banka Bioloo Ltd belong to?
Banka Bioloo Ltd is classified under the Construction sector, in the Civil Construction industry.
What is the market capitalisation of Banka Bioloo Ltd?
Banka Bioloo Ltd has a market capitalisation of ₹85.3 Cr, which places it in the Small Cap band.
What is the PE ratio of Banka Bioloo Ltd?
Banka Bioloo Ltd trades at a PE ratio of 263.81, against a book value of ₹36.19 per share.
What is the 52-week high and low of Banka Bioloo Ltd?
Over the last 52 weeks Banka Bioloo Ltd has traded between ₹41 and ₹97.88.
What is the Return on Equity (ROE) of Banka Bioloo Ltd?
Banka Bioloo Ltd reported a return on equity of 0.92%. Its debt-to-equity ratio is 1.03.
Company Information
Incorporated in 2012, Banka Bioloo Ltd does manufacturing, supply, installation and O&M of Bio toilets and Controlled discharge toilet system[1]
Website bankabio.com
CEO Mr. Sanjay Kumar Banka
Employees 1,109
Listed 2020-10-29
Face Value ₹ 10
Issued Size 1,08,92,857
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/BANKA.md for Banka Bioloo Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live,
structured queries instead of documents, use our MCP server.